Susan Thomas, Chief Commercial Officer at LucyRx, has been awarded a Silver and a Bronze Stevie® Award in the categories of Most Innovative Woman of the Year – Healthcare and Female Executive of the Year, respectively, in the 22nd annual Stevie Awards for Women in Business.
Elisa Muller, Vice President of Legal and Chief Compliance Officer of LucyRx, recently authored an article in BenefitsPRO about pharmacy benefit reform—the legislative efforts to increase transparency, fairness and accountability in the PBM industry.
LucyRx just raised the bar for PBM accountability. The Outcomes Accord brings together employers, brokers, and consultants to track what really matters—transparent results, measurable outcomes, and restored trust in prescription care.
LucyRx completes acquisition of CerpassRx, strengthening clinical excellence and expanding access to innovative prescription care. Combination reinforces LucyRx’s proven model of client-first prescription care, expands scale, and enhances clinical depth.
Alex Motola, LucyRx Chief Business Officer, Named Among Becker’s Hospital Review’s 100 Healthcare Leaders Under 40
Susan Thomas, Chief Commercial Officer of LucyRx, recently authored an article for Pharmaceutical Executive on what innovation in PBM management really looks like.
As PBM satisfaction declines industrywide, LucyRx stands out with exceptional service, transparency, and results.
LucyRx Chief Executive Officer David Blair was recently featured in SIIA’s The Self-Insurer, where he spoke with reporter Bruce Shutan about the intersection of GLP-1 medications and member education.
David Blair, CEO of LucyRx, was one of only eight leaders to be named a PBMI Innovator by Managed Healthcare Executive and the Pharmacy Benefit Management Institute (PBMI).
David Blair, CEO of LucyRx, was one of only eight leaders to be named a PBMI Innovator by Managed Healthcare Executive and the Pharmacy Benefit Management Institute (PBMI).